InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Wednesday, 04/20/2022 5:03:21 PM

Wednesday, April 20, 2022 5:03:21 PM

Post# of 42654
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm

https://www.mdpi.com/1422-0067/23/9/4545

"Lenzilumab, a recombinant monoclonal antibody against human GM-CSF, also has the potential to be used to treat COVID-19. Patients who received intravenous lenzilumab treatment had reduced progression to ARDS and reduced inflammatory markers"

(from LPF_91 on Stocktwits)